The uricosuric action of halofenate (MK-185) in patients with hyperuricemia or uncomplicated primary gout and hyperlipidemia
- 1 November 1973
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 18 (3) , 353-362
- https://doi.org/10.1016/0021-9150(73)90065-8
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Hypolipidemic, uricosuric, and thyroxine‐displacing effects of MK‐185 (halofenate)Clinical Pharmacology & Therapeutics, 1971
- The effect of MK‐185 on some aspects of uric acid metabolismClinical Pharmacology & Therapeutics, 1970
- Alterations of Factors Predisposing to Coronary Heart DiseaseAnnals of Internal Medicine, 1968
- Multiple Range and Multiple F TestsPublished by JSTOR ,1955